Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News
LucidSearch
QuickAnswers

Contact Us

Search

stiff person syndrome

Rare Disease news

Rare Disease Today—December 18, 2025

This week’s rare disease update spotlights key developments, regulatory…

Cell_Gene_Therapy

Cell and Gene Therapy Today—December 18, 2025

This week’s Cell & Gene Therapy update highlights major developments,…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Rare Disease Video Recap—December 18, 2025
Cardiovascular Video Recap—December 18, 2025
Cardiovascular Today—December 18, 2025
Rare Disease Today—December 18, 2025
Cell and Gene Therapy Today—December 18, 2025

Tags

advanced therapies AI in Aesthetics AI in dermatology Amycretin Anthracycline induced cardiotoxicity Aromatase Inhibitors bioinformatics biotech investment blood biomarkers breast cancer genomics cancer ckd corporate venture capital Datar Cancer Genetics Dayra Therapeutics drug supply chain EAS 2025 Elranatamab ESMO 2021 Fenfluramine gene editing gene therapy approval GEN Pharmaceuticals heart valve treatment hematology ICM+ investment Ischemic heart disease KDCA metastatic uveal melanoma molecular design Mucosal immunity myocardial infarction NFTs in healthcare non viral vectors noom oncology trials Orna Therapeutics PD-L1 combined positive score pharma prevention remote patient monitoring retinal ai Sema4 skin conditions

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Rare Disease Video Recap—December 18, 2025
Cardiovascular Video Recap—December 18, 2025
Cardiovascular Today—December 18, 2025
Rare Disease Today—December 18, 2025
Cell and Gene Therapy Today—December 18, 2025

TAGS

advanced therapies AI in Aesthetics AI in dermatology Amycretin Anthracycline induced cardiotoxicity Aromatase Inhibitors bioinformatics biotech investment blood biomarkers breast cancer genomics cancer ckd corporate venture capital Datar Cancer Genetics Dayra Therapeutics drug supply chain EAS 2025 Elranatamab ESMO 2021 Fenfluramine gene editing gene therapy approval GEN Pharmaceuticals heart valve treatment hematology ICM+ investment Ischemic heart disease KDCA metastatic uveal melanoma molecular design Mucosal immunity myocardial infarction NFTs in healthcare non viral vectors noom oncology trials Orna Therapeutics PD-L1 combined positive score pharma prevention remote patient monitoring retinal ai Sema4 skin conditions

Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News
LucidSearch
QuickAnswers

© 2025 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy